Protocol No.: EFC17504
- Title
- A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis
- Principal Investigator
- Ward, Melanie
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Other
- Participating Institutions
- Health Sciences Center
- West Virginia University
- Contact
- Lauren Chase, RN
- Clinical Research Specialist
- Phone: +1 304-598-4000
- Email: lauren.chase@wvumedicine.org